Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14742614rdf:typepubmed:Citationlld:pubmed
pubmed-article:14742614lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C0332197lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C1996904lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C1880497lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C0750491lld:lifeskim
pubmed-article:14742614lifeskim:mentionsumls-concept:C0133821lld:lifeskim
pubmed-article:14742614pubmed:issue2lld:pubmed
pubmed-article:14742614pubmed:dateCreated2004-1-26lld:pubmed
pubmed-article:14742614pubmed:abstractTextOligoclonal free kappa bands are present as frequently as oligoclonal IgG bands in the cerebrospinal fluid (CSF) from patients with definite multiple sclerosis (MS) and can even occur in the absence of oligoclonal IgG. As such, they too are markers of an ongoing intrathecal immune process.lld:pubmed
pubmed-article:14742614pubmed:languageenglld:pubmed
pubmed-article:14742614pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14742614pubmed:citationSubsetIMlld:pubmed
pubmed-article:14742614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14742614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14742614pubmed:statusMEDLINElld:pubmed
pubmed-article:14742614pubmed:monthFeblld:pubmed
pubmed-article:14742614pubmed:issn0022-3050lld:pubmed
pubmed-article:14742614pubmed:authorpubmed-author:HenryHHlld:pubmed
pubmed-article:14742614pubmed:authorpubmed-author:SchluepMMlld:pubmed
pubmed-article:14742614pubmed:authorpubmed-author:DuprezTTlld:pubmed
pubmed-article:14742614pubmed:authorpubmed-author:GoffetteSSlld:pubmed
pubmed-article:14742614pubmed:authorpubmed-author:SindicC J MCJlld:pubmed
pubmed-article:14742614pubmed:issnTypePrintlld:pubmed
pubmed-article:14742614pubmed:volume75lld:pubmed
pubmed-article:14742614pubmed:ownerNLMlld:pubmed
pubmed-article:14742614pubmed:authorsCompleteYlld:pubmed
pubmed-article:14742614pubmed:pagination308-10lld:pubmed
pubmed-article:14742614pubmed:dateRevised2008-11-20lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:meshHeadingpubmed-meshheading:14742614...lld:pubmed
pubmed-article:14742614pubmed:year2004lld:pubmed
pubmed-article:14742614pubmed:articleTitleDetection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.lld:pubmed
pubmed-article:14742614pubmed:affiliationService de Neurologie, Cliniques universitaires Saint Luc, UCL, Brussels, Belgium.lld:pubmed
pubmed-article:14742614pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14742614pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed